CR-002 for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Oct 2026: Trial started, NCT07909031
  2. 2 Nov 2026: Trial registered, NCT07909031

The trials

NCT07909031: CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

State
Under way
Phase
Phase 1 and Phase 2
People
219 planned
Started
21 Oct 2026
Primary completion
Oct 2028
Arms
CR-002 Dose Escalation, CR-002 Backfill
Results
None posted
  1. 21 Oct 2026: Trial started
  2. 2 Nov 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.